- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Immunotherapies targeting stimulatory pathways and beyond ; volume:14 ; number:1 ; day:12 ; month:5 ; year:2021 ; pages:1-31 ; date:12.2021
Journal of hematology & oncology ; 14, Heft 1 (12.5.2021), 1-31, 12.2021
- Urheber
-
Marin-Acevedo, Julian A.
Kimbrough, ErinMarie O.
Manochakian, Rami
Zhao, Yujie
Lou, Yanyan
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13045-021-01085-3
- URN
-
urn:nbn:de:101:1-2021091221463549409536
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:36 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Marin-Acevedo, Julian A.
- Kimbrough, ErinMarie O.
- Manochakian, Rami
- Zhao, Yujie
- Lou, Yanyan
- SpringerLink (Online service)
Ähnliche Objekte (12)
Cancer immunotherapies targeting the PD-1 signaling pathway
Cross-talk of inhibitory and stimulatory signalling pathways of human platelets
Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity
Inorganic nanosheets facilitate humoral immunity against medical implant infections by modulating immune co-stimulatory pathways
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Advances in Prostate Cancer Immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
Cancer immunotherapies targeting the PD-1 signaling pathway
Cross-talk of inhibitory and stimulatory signalling pathways of human platelets
Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity
Inorganic nanosheets facilitate humoral immunity against medical implant infections by modulating immune co-stimulatory pathways
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Advances in Prostate Cancer Immunotherapies
Implantable Biomaterials for Cancer Immunotherapies
Cancer immunotherapies targeting the PD-1 signaling pathway
Cross-talk of inhibitory and stimulatory signalling pathways of human platelets
Targeting Co-Stimulatory Receptors of the TNF Superfamily for Cancer Immunotherapy
Immunotherapies in solid tumors
Immunotherapies in rare cancers
Structure-guided engineering of immunotherapies targeting TRBC1 and TRBC2 in T cell malignancies
Combined targeting of co-stimulatory (OX40) and co-inhibitory (CTLA-4) pathways elicits potent effector T cells capable of driving robust anti-tumor immunity
Inorganic nanosheets facilitate humoral immunity against medical implant infections by modulating immune co-stimulatory pathways
Neurotoxicity of novel cancer immunotherapies
Emerging Immunotherapies for Parkinson Disease
Advances in Prostate Cancer Immunotherapies